Skip to main content
Clinical Trials/ACTRN12621001582842
ACTRN12621001582842
Recruiting
N/A

Testing a genetics-specific patient screening tool to personalise cancer genetic counselling and determine the impact on patient empowerment

Peter MacCallum Cancer Centre0 sites246 target enrollmentNovember 19, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Inherited predisposition to cancer
Sponsor
Peter MacCallum Cancer Centre
Enrollment
246
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Peter MacCallum Cancer Centre

Eligibility Criteria

Inclusion Criteria

  • Individuals who have an increased risk of a hereditary cancer syndrome;
  • Aged 18 years or older;
  • Literate in English;
  • Reasonable internet access and capacity to complete computer\-based surveys.

Exclusion Criteria

  • Have a known cognitive impairment;
  • Eligible for the PRiMo study (HREC no. HREC/64060/PMCC; ACTRN12621000009819\).

Outcomes

Primary Outcomes

Not specified

Similar Trials